Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6528
    +0.0028 (+0.43%)
     
  • OIL

    83.14
    +0.33 (+0.40%)
     
  • GOLD

    2,340.10
    +1.70 (+0.07%)
     
  • Bitcoin AUD

    98,053.25
    -4,105.54 (-4.02%)
     
  • CMC Crypto 200

    1,355.48
    -27.10 (-1.96%)
     
  • AUD/EUR

    0.6089
    +0.0019 (+0.31%)
     
  • AUD/NZD

    1.0956
    +0.0015 (+0.13%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,098.99
    +58.61 (+0.73%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,997.86
    -90.84 (-0.50%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Why BioNTech Was Tumbling Again Today

This isn't shaping up to be a banner week for BioNTech (NASDAQ: BNTX). The bellwether coronavirus stock took it on the chin Monday and was being similarly battered by investors Tuesday because of post-earnings analyst price target cuts. Following second-quarter results that disappointed many investors, several analysts recalibrated their takes on BioNTech stock Tuesday.